The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

BACKGROUND: We compared the lowering effects of pemafibrate and omega-3 fatty acid ethyl on fasting apolipoprotein (apo) B-48 (apoB-48), a marker that reflects postprandial hypertriglyceridemia, which is one of the residual risks for atherosclerotic cardiovascular disease (ASCVD) with statin treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Yasutaka, Sakuma, Ichiro, Hiramitsu, Shinya, Okada, Mizuho, Ueda, Shinichiro, Sakurai, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905248/
https://www.ncbi.nlm.nih.gov/pubmed/36760560
http://dx.doi.org/10.3389/fcvm.2023.1094100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905248/
https://www.ncbi.nlm.nih.gov/pubmed/36760560
http://dx.doi.org/10.3389/fcvm.2023.1094100

Ejemplares similares